PROCEPT BioRobotics (PRCT) Net Income towards Common Stockholders (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$26.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 37.2% year-over-year to -$26.9 million in Q2 2026; TTM through Jun 2026 was -$114.5 million, a 29.34% decrease from a year earlier, with the FY2025 full-year figure at -$95.6 million, down 4.55% from the prior year.
• Net Income towards Common Stockholders was -$26.9 million for Q2 2026 at PROCEPT BioRobotics, up from -$31.6 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$17.1 million in Q1 2022 and troughed at -$31.9 million in Q4 2025.
• A 5-year average of -$25.5 million and a median of -$26.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders tumbled 70.88% in 2023 and surged 32.6% in 2024, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at -$25.9 million in 2022, then declined by 18.44% to -$30.7 million in 2023, then jumped by 32.6% to -$20.7 million in 2024, then slumped by 54.43% to -$31.9 million in 2025, then grew by 15.89% to -$26.9 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$26.9 million (Q2 2026), -$31.6 million (Q1 2026), and -$31.9 million (Q4 2025), per Business Quant data.